PCSK9 and Ventricular arrhythmia: Third, PCSK9 inhibitors have been demonstrated to protect coronary artery endothelial function [37,38], which may decrease the probability of plaque rupture and prevent ischemia-induced electrophysiological disturbances that predispose patients to ventricular arrhythmias [6].